Cumberland PharmaceuticalsCPIX
13F holders, Q4 2024 (December 31)20holders −2
1new positions
3sold out
1famous investor
$2.37avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, down 2 from Q3 2024. 1 opened new positions and 3 sold out. The largest holders were Renaissance Technologies ($1.2M), Vanguard Group Inc. ($887K) and Dimensional Fund Advisors LP ($647K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 3 | $17K |
All 13F filers, Q3 2024 → Q4 2024: 19,709 shares bought and 221,483 shares sold, net −201,774 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Renaissance Technologies | 0.00% | Reduce -4.0% | 507,163 | $1.2M |
| Vanguard Group Inc. | 0.00% | No change | 374,251 | $887K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -3.9% | 272,969 | $647K |
| Acadian Asset Management LLC | 0.00% | No change | 188,164 | $444K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -35.8% | 184,155 | $436K |
| Bank of New York Mellon Corp | 0.00% | Add +0.0% | 75,269 | $178K |
| Geode Capital Management, LLC | 0.00% | No change | 74,305 | $176K |
| BlackRock, Inc. | 0.00% | Reduce -61.3% | 42,581 | $101K |
| Two Sigma Investments, LP | 0.00% | Add +94.3% | 37,649 | $89K |
| State Street Corp. | 0.00% | No change | 33,700 | $80K |
| Cresset Asset Management, LLC | 0.00% | Add +4.7% | 22,275 | $53K |
| Northern Trust Corp. | 0.00% | Reduce -3.7% | 15,712 | $37K |
| UBS Group AG | 0.00% | Reduce -15.3% | 8,195 | $19K |
| Morgan Stanley | 0.00% | No change | 2,660 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -64.0% | 2,218 | $5K |
| Capital Advisors, Ltd. LLC | 0.00% | New | 437 | $1K |
| Wells Fargo & Company | 0.00% | No change | 250 | $593 |
| Bank of America Corp. | 0.00% | Reduce -53.2% | 65 | $154 |
| JPMorgan Chase & Co. | 0.00% | Reduce -91.3% | 19 | $45 |
| Huntington National Bank | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.